At 15.1x earnings and 11.5x forward earnings, DKL screens optically inexpensive, but this is not a clean value story. The forward multiple implies earnings compression versus the current EPS of 10.5 and next year estimate of $3.30, which signals a major normalization event. The Altman Z-Score of 1.2 puts the company in distress territory, meaning balance sheet fragility is real despite a $2,667M market cap. This is not a mispriced hyper-growth asset; it is a leveraged income vehicle trading at a moderate multiple with real financial risk embedded.